Европейски съюз - български - EMA (European Medicines Agency)

pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - Имуносупресори - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.

Европейски съюз - български - EMA (European Medicines Agency)

dechra regulatory b.v. - тулатромицин - Антибактериални средства за системна употреба - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. Наличието на болестта в стадото трябва да бъде установено преди метафилактичното лечение. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. Наличието на болестта в стадото трябва да бъде установено преди метафилактичното лечение. the product should only be used if pigs are expected to develop the disease within 2–3 days. Овца: лечение на ранните стадии на инфекцията pododermatitis (копытная гниене), свързани с вирулентным пилей dichelobacter nodosus, които изискват системно лечение.

Европейски съюз - български - EMA (European Medicines Agency)

dechra regulatory b.v. - миртазапин - psychoanaleptics, antidepressants in combination with psycholeptics - Котки - За увеличаване на теглото на тялото при котките, имат лош апетит и загуба на тегло в резултат на хронични заболявания.

Европейски съюз - български - EMA (European Medicines Agency)

astrazeneca ab - дадаглифлозин пропандиол монохидрат - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - Лекарства, използвани при диабет - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. в допълнение към други лекарства за лечение на захарен диабет тип 2 . for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 и 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.

Европейски съюз - български - EMA (European Medicines Agency)

astrazeneca ab - дадаглифлозин пропандиол монохидрат - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - Лекарства, използвани при диабет - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. в допълнение към други лекарства за лечение на захарен диабет тип 2 . for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 и 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.

Европейски съюз - български - EMA (European Medicines Agency)

zoetis belgium sa - live recombinant e2 gene-deleted bovine viral diarrhoea virus containing classical swine fever virus e2 gene (cp7_e2alf) - live viral vaccines, immunologicals for suidae - Прасета - За активна имунизация на свинете с 7 седмична възраст и по-нататък, за да се предотврати смъртността и намаляване на инфекции и заболявания, причинени от вируса на класическата чума свинете (csfv). onset of immunity: 14 days after vaccinationduration of immunity: at least 6 months after vaccinationfor active immunisation of breeding females to reduce transplacental infection caused by csfv. onset of immunity: 21 days after vaccinationduration of immunity has not been demonstrated.

Европейски съюз - български - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - Лекарства, използвани при диабет - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 и 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure.  chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.

Европейски съюз - български - EMA (European Medicines Agency)

ceva santé animale - influenza a virus/human strain: a/jena/vi5258/2009 (h1n1)pdm09, inactivated - Имунологични, инактивирани вирусни ваксини за прасета, вирус на свински грип - Прасета - Активна имунизация на свинете, на възраст от 8 седмици и след това срещу пандемичен грип h1n1 на свинския грип, за да се намали вирусния товар в белите дробове и вирусна экскреция. the vaccine can be used during pregnancy up to three weeks before expected farrowing and during lactation lactation.

Европейски съюз - български - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - Лекарства, използвани при диабет - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 и 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Европейски съюз - български - EMA (European Medicines Agency)

janssen-cilag international nv - canagliflozin - Захарен диабет тип 2 - Лекарства, използвани при диабет - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 и 5.